Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
01/15/2004
Trade Name:
Zithromax Tablets
Generic Name or Proper Name (*):
azithromycin
Indications Studied:
Treatment of acute bacterial sinusitis (sinus infection) in patients 6 months of age and older
Label Changes Summary:
Effectiveness extrapolated from adult sinusitis studies and from pediatric acute otitis media studies Clinical studies conducted in pediatric patients 3 years to 16 years of age to determine PK and safety for oral suspension Safety and effectiveness in patients under 6 months of age have not been established Side effects seen in pediatric patients were comparable to those seen in adults, with different incidence rates for the dosage regimens recommended in pediatric patients Dosing regimen established Partial waiver < 6 months of age because too few patients to study New indication
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Pfizer
NNPS:
FALSE'
Therapeutic Category:
Antibiotic
-
-